Zhongyuan Union Cell & Gene Engineering (SHSE:600645) ROCE % : 6.56% (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhongyuan Union Cell & Gene Engineering's annualized ROCE % for the quarter that ended in Sep. 2024 was 6.56%.

Zhongyuan Union Cell & Gene Engineering ROCE % Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering ROCE % Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

3.71

-2.38

6.17

4.20

3.45

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															6.55	-4.15	5.82	5.95	6.56

Zhongyuan Union Cell & Gene Engineering ROCE % Calculation

Zhongyuan Union Cell & Gene Engineering's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	133.504	/	( ( (5284.619 - 1471.495)	+	(5411.355 - 1481.737) )	/ 2 )
	=	133.504	/	( (3813.124	+	3929.618)	/ 2 )
	=	133.504	/	3871.371
	=	3.45 %

Zhongyuan Union Cell & Gene Engineering's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	250.456	/	( ( (5309.097 - 1467.657)	+	(5280.484 - 1481.844) )	/ 2 )
	=	250.456	/	( ( 3841.44	+	3798.64 )	/ 2 )
	=	250.456	/	3820.04
	=	6.56 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhongyuan Union Cell & Gene Engineering ROCE % Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines